161 related articles for article (PubMed ID: 1974512)
1. The role of multiple action agents in hypertension.
Lund-Johansen P; Omvik P
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S89-95. PubMed ID: 1974512
[TBL] [Abstract][Full Text] [Related]
2. Essential hypertension: hemodynamic and therapeutic changes over 20 years.
Lund-Johansen P
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S1-7. PubMed ID: 1721971
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
4. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
Omvik P; Lund-Johansen P
Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
[TBL] [Abstract][Full Text] [Related]
5. Long-term hemodynamic effects of antihypertensive treatment.
Lund-Johansen P; Omvik P; Nordrehaug JE
Clin Investig; 1992; 70 Suppl 1():S58-64. PubMed ID: 1350486
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
Lund-Johansen P; Omvik P; Nordrehaug JE; White W
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
[TBL] [Abstract][Full Text] [Related]
7. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
Eggertsen R
Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
[TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol on atrial natriuretic peptide, catecholamines, and hemodynamics in hypertension at rest and during exercise.
Omvik P; Lund-Johansen P; Myking O
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S90-6. PubMed ID: 1378157
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect.
Lund-Johansen P; Omvik P
Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963
[TBL] [Abstract][Full Text] [Related]
10. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
Lund-Johansen P
Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol in hypertension treatment.
Stafylas PC; Sarafidis PA
Vasc Health Risk Manag; 2008; 4(1):23-30. PubMed ID: 18629377
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of beta-blocking compounds possessing vasodilating activity: a review of labetalol, prizidilol, and dilevalol.
Lund-Johansen P
J Cardiovasc Pharmacol; 1988; 11 Suppl 2():S12-7. PubMed ID: 2464093
[TBL] [Abstract][Full Text] [Related]
13. Age hemodynamics and exercise in essential hypertension: difference between beta-blockers and dihydropyridine calcium antagonists.
Lund-Johansen P
J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S7-13. PubMed ID: 2483573
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients.
Weber K; Bohmeke T; van der Does R; Taylor SH
Am J Hypertens; 1998 May; 11(5):614-7. PubMed ID: 9633801
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
16. Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.
Wendt T
Clin Investig; 1992; 70 Suppl 1():S93-7. PubMed ID: 1350491
[TBL] [Abstract][Full Text] [Related]
17. Experimental and clinical pharmacology of carvedilol and other drugs combining vasodilation and beta-adrenoceptor antagonism in a single molecule.
Strein K; Sponer G
Z Kardiol; 1990; 79 Suppl 3():89-98. PubMed ID: 1983054
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
Cournot A; Lim C; Duchier J; Safar M
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of carvedilol, a vasodilating beta-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension.
Maggi E; Marchesi E; Covini D; Negro C; Perani G; Bellomo G
J Cardiovasc Pharmacol; 1996 Apr; 27(4):532-8. PubMed ID: 8847870
[TBL] [Abstract][Full Text] [Related]
20. Acute haemodynamic effects of carvedilol in essential hypertension at rest and during exercise.
Omvik P; Lund-Johansen P
Eur Heart J; 1991 Jun; 12(6):736-40. PubMed ID: 1860471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
